JGC
ACH

J. Goldman & Co’s Accendra Health ACH Stock Holding History

J. Goldman & Co’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-734,797
Closed -$6.69M – 568
2025
Q2 		$6.69M Buy
+734,797
New +$5.42M 0.16% 169

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

J. Goldman & Co's ACH Position: Q3 2025 in Review

J. Goldman & Co sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 734,797 shares — an estimated $6.69M sold.

J. Goldman & Co first reported a position in ACH in Q2 2025 and held it in 1 quarter. The position peaked at $6.69M in Q2 2025. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • J. Goldman & Co reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 734,797 Accendra Health shares in Q3 2025, an estimated $6.69M.
  • J. Goldman & Co first reported a position in Accendra Health in Q2 2025 and held it in 1 quarter.
  • J. Goldman & Co's Accendra Health position peaked at $6.69M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.